MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neuropharm.2019.107919

Медицинская библиотека · Neuropharmacology · 2019

Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.

Panagiotakopoulou Vasiliki, Botsakis Konstantinos, Delis Foteini, Mourtzi Theodora, Tzatzarakis Manolis N, Dimopoulou Aggeliki, Poulia Nafsika, Antoniou Katerina, Stathopoulos Georgios T, Matsokis Nikolaos, Charalampopoulos Ioannis, Gravanis Achilleas, Angelatou Fevronia

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BNN-20 is a synthetic microneurotrophin, long-term (P1-P21) administration of which exerts potent neuroprotective effect on the "weaver" mouse, a genetic model of progressive, nigrostriatal dopaminergic degeneration. The present study complements and expands our previous work, providing evidence that BNN-20 fully protects the dopaminergic neurons even when administration begins at a late stage of dopaminergic degeneration (>40%). Since neuroinflammation plays a critical role in Parkinson's disease, we investigated the possible anti-neuroinflammatory mechanisms underlying the pharmacological action of BNN-20. The latter was shown to be microglia-mediated, at least in part. Indeed, BNN-20 induced a partial, but significant, reversal of microglia hyperactivation, observed in the untreated "weaver" mouse. Furthermore, it induced a shift in microglia polarization towards the neuroprotective M2 phenotype, suggesting a possible beneficial shifting of microglia activity. This observation was further supported by morphometric measurements. Moreover, BDNF levels, which were severely reduced in the "weaver" mouse midbrain, were restored to normal even after short-term BNN-20 administration. Experiments in "weaver"/NGL (dual GFP/luciferase-NF-κВ reporter) mice using bioluminescence after a short BNN-20 treatment (P60-P74), have shown that the increase of BDNF production was specifically mediated through the TrkB-PI3K-Akt-NF-κB signaling pathway. Interestingly, long-term BNN-20 treatment (P14-P60) significantly increased dopamine levels in the "weaver" striatum, which seems to be associated with the improved motor activity observed in the treated mutant animals. In conclusion, our findings suggest that BNN-20 may serve as a lead molecule for new therapeutic compounds for Parkinson's disease, combining strong anti-neuroinflammatory and neuroprotective properties, leading to elevated dopamine levels and improved motor activity.

Для цитирования: Panagiotakopoulou Vasiliki, Botsakis Konstantinos, Delis Foteini, Mourtzi Theodora, Tzatzarakis Manolis N, Dimopoulou Aggeliki, Poulia Nafsika, Antoniou Katerina, Stathopoulos Georgios T, Matsokis Nikolaos, Charalampopoulos Ioannis, Gravanis Achilleas, Angelatou Fevronia. Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.. Neuropharmacology. 2019. DOI: 10.1016/j.neuropharm.2019.107919.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.